282. 先天性赤血球形成異常性貧血 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 2 / 薬物数 : 3 - (DrugBank : 2) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 7
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Luspatercept
FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
2023 Phase 2 EUCTR2020-005736-30-IT Italy
Omeprazole
Soroka University Medical Center
2013 Phase 4 NCT01795794 -
Reblozyl
FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
2023 Phase 2 EUCTR2020-005736-30-IT Italy
FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
2023 Phase 2 EUCTR2020-005736-30-IT Italy
Omeprazole
Soroka University Medical Center
2013 Phase 4 NCT01795794 -
Reblozyl
FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
2023 Phase 2 EUCTR2020-005736-30-IT Italy